chevron_leftBack
As of 15 June 2026, Korean Drug Co., Ltd. has a market cap of $30.06M USD, ranking #34231 globally and #2115 in South Korea.
It ranks #3089 in the Healthcare sector, and #1051 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$30.06MUSD
45.72B KRW
Enterprise Value
$10.4MUSD
15.78B KRW
Revenue (TTM)
$41.1MUSD
62.51B KRW
EBITDA (TTM)
$5.85MUSD
8.88B KRW
Net Income (TTM)
$4.28MUSD
6.51B KRW
EBITDA Margin
14%
Profit Margin
10%
PE Ratio
7.0
PS Ratio
0.7
PB Ratio
0.6
EV/EBITDA
1.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
270
Founded
1980
Website
nicepharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.3% | 2.9% | 6.3% | 1.4% | -0.5% | -12% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
014570
고려제약(주)
ISIN: KR7014570006
Shares Out.:
Shares Outstanding:
10.824M1
Shares Float:
5.18M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
4,190 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Korean Drug Co., Ltd.
Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
30K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
22K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
17K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
16K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
15K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
15K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
3M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
2M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
1M%
|
97.4
|
|
SIX: RO
|
$321.52B
1M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
961K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
913K%
218.9B CHF
|
20.5
|
chevron_leftBack